AI Assistant
Blog
Pricing
Log In
Sign Up
Increasing the prescription rate of β-blockers is beneficial for patients with chronic obstructive pulmonary and cardiovascular disease
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
